# Alcinous Pharmaceuticals, Inc. — Form D

Alcinous Pharmaceuticals, Inc. of RUMFORD, RI, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-16. The offering totals $600K, of which $100K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-04-16
- Form: D
- Accession: 0001809300-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $100K
- Remaining: $500K
- Minimum investment: $1
- Investors: 2
- Date of first sale: 2020-04-03
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-365160

## Issuer

- Name: Alcinous Pharmaceuticals, Inc.
- CIK: 0001809300
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 14 BICKNELL AVENUE, RUMFORD, RI, 02916
- Phone: 4015293190

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Benjamin J Barlock | Director | Rumford, RI |
| Nicholas A DaSilva | Director | Rumford, RI |
| Kenneth N Rose | Director | Rumford, RI |
| Nicholas A DaSilva | Executive Officer | Rumford, RI |
| Kenneth N Rose | Executive Officer | Rumford, RI |

## More

- [CIK 1809300 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1809300&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001809300-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.